PT824598E - Processo para o acoplamento especifico de um grupo de bloqueio da extremidade 5' de um fragmento de arnm e preparacao do arnm e do adnc completo - Google Patents

Processo para o acoplamento especifico de um grupo de bloqueio da extremidade 5' de um fragmento de arnm e preparacao do arnm e do adnc completo

Info

Publication number
PT824598E
PT824598E PT96914259T PT96914259T PT824598E PT 824598 E PT824598 E PT 824598E PT 96914259 T PT96914259 T PT 96914259T PT 96914259 T PT96914259 T PT 96914259T PT 824598 E PT824598 E PT 824598E
Authority
PT
Portugal
Prior art keywords
mrna
pct
preparation
fragment
specific coupling
Prior art date
Application number
PT96914259T
Other languages
English (en)
Inventor
Irena Merenkova
Jean-Baptiste Gabriel Edwards
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9505221A external-priority patent/FR2733765B1/fr
Application filed by Genset Sa filed Critical Genset Sa
Publication of PT824598E publication Critical patent/PT824598E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
PT96914259T 1995-05-02 1996-04-29 Processo para o acoplamento especifico de um grupo de bloqueio da extremidade 5' de um fragmento de arnm e preparacao do arnm e do adnc completo PT824598E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9505221A FR2733765B1 (fr) 1995-05-02 1995-05-02 Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm
FR9509467A FR2733762B1 (fr) 1995-05-02 1995-08-03 Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet

Publications (1)

Publication Number Publication Date
PT824598E true PT824598E (pt) 2003-03-31

Family

ID=26231928

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96914259T PT824598E (pt) 1995-05-02 1996-04-29 Processo para o acoplamento especifico de um grupo de bloqueio da extremidade 5' de um fragmento de arnm e preparacao do arnm e do adnc completo

Country Status (12)

Country Link
US (1) US6022715A (pt)
EP (1) EP0824598B1 (pt)
JP (1) JPH11510364A (pt)
AT (1) ATE227346T1 (pt)
AU (1) AU719217B2 (pt)
CA (1) CA2220045C (pt)
DE (1) DE69624695T2 (pt)
DK (1) DK0824598T3 (pt)
ES (1) ES2186778T3 (pt)
FR (1) FR2733762B1 (pt)
PT (1) PT824598E (pt)
WO (1) WO1996034981A2 (pt)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766891A (en) 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
JP3441899B2 (ja) * 1996-11-01 2003-09-02 理化学研究所 完全長ｃＤＮＡライブラリーの作成方法
DE69827745T2 (de) 1997-06-12 2005-11-10 Sloan-Kettering Institute For Cancer Research Kovalente bindung von dna zu rna strängen katalysiert durch vaccinia topoisomerase
ES2287979T3 (es) * 1997-08-01 2007-12-16 Serono Genetics Institute S.A. Est 5' para proteinas secretadas identificadas a partir de tejidos cerebrales.
EP1367124A1 (en) * 1997-08-01 2003-12-03 Genset 5' ests for secreted proteins expressed in muscle and other mesodermal tissues
WO1999025825A2 (en) * 1997-11-13 1999-05-27 Genset EXTENDED cDNAs FOR SECRETED PROTEINS
PT1375514E (pt) * 1997-08-01 2006-10-31 Serono Genetics Inst Sa Ests 5' para proteinas secretadas expressas em varios tecidos
WO1999006439A2 (en) * 1997-08-01 1999-02-11 Genset 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM
WO1999006550A2 (en) * 1997-08-01 1999-02-11 Genset 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE
US7393663B2 (en) 1997-08-01 2008-07-01 Serono Genetics Institute S.A. Expressed sequence tags and encoded human proteins
CA2297157A1 (en) * 1997-08-01 1999-02-11 Genset 5' ests for secreted proteins expressed in testis and other tissues
ES2267192T3 (es) * 1997-08-01 2007-03-01 Serono Genetics Institute S.A. Ests 5' para proteinas secretadas no especificas de tejido.
US6222029B1 (en) 1997-08-01 2001-04-24 Genset 5′ ESTs for secreted proteins expressed in brain
FR2767135B1 (fr) 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
AU9645598A (en) * 1997-10-22 1999-05-10 Helix Research Institute Method for screening full-length cdna clones
US6573068B1 (en) 1997-11-13 2003-06-03 Genset, S. A. Claudin-50 protein
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
US20060286639A1 (en) * 1997-11-13 2006-12-21 Serono Genetics Institute S.A. Complementary DNAs encoding proteins with signal peptides
EP1903111A3 (en) * 1997-11-13 2008-07-02 Serono Genetics Institute S.A. Extended cDNAs for secreted proteins
US6312922B1 (en) 1998-02-09 2001-11-06 Genset Complementary DNAs
EP1037977B1 (en) * 1997-12-17 2009-08-26 Serono Genetics Institute S.A. EXTENDED cDNAs FOR SECRETED PROTEINS
AU764571B2 (en) * 1998-04-09 2003-08-21 Genset S.A. 5' ESTs and encoded human proteins
US7223727B2 (en) 1998-04-09 2007-05-29 Serono Genetics Institute S.A. GSSP4 polynucleotides and polypeptides and uses thereof
US6783961B1 (en) 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
DE69938837D1 (de) 1998-11-04 2008-07-10 Serono Genetics Inst Sa Genomische und vollständige cdna sequenzen von menschlichem adipozyten spezifischem apm1 und biallelische marker davon
US6455280B1 (en) 1998-12-22 2002-09-24 Genset S.A. Methods and compositions for inhibiting neoplastic cell growth
ATE427362T1 (de) 1999-02-10 2009-04-15 Serono Genetics Inst Sa Polymorphe marker des lsr-gens
EP1586645A3 (en) 1999-02-25 2006-02-22 Ceres Incorporated Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
JP2002539799A (ja) * 1999-03-19 2002-11-26 ジェネティックス・インスチチュート・インコーポレーテッド プライマー結合ベクター伸長（ＰＡＶＥ）：５’−指向ｃＤＮＡクローニング法
CA2367723A1 (en) * 1999-03-19 2000-09-28 Invitrogen Corporation Methods of obtaining full-length nucleic acid sequences using e. coli topoisomerase iii and its homologs
US7485715B2 (en) 1999-06-18 2009-02-03 Ceres, Inc. Sequence-determined DNA encoding AP2 domain polypeptides
US7479555B2 (en) 1999-07-21 2009-01-20 Ceres, Inc. Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
US6989367B2 (en) 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
US6566332B2 (en) 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US7338787B2 (en) 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
US20020058617A1 (en) 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass
AU2001243232A1 (en) 2000-02-25 2001-09-03 University Of South Carolina Research Foundation Topoisomerase linker-mediated amplification methods
US6387624B1 (en) * 2000-04-14 2002-05-14 Incyte Pharmaceuticals, Inc. Construction of uni-directionally cloned cDNA libraries from messenger RNA for improved 3′ end DNA sequencing
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6916632B2 (en) 2000-08-21 2005-07-12 Invitrogen Corporation Methods and reagents for molecular cloning
US6875907B2 (en) 2000-09-13 2005-04-05 Pioneer Hi-Bred International, Inc. Antimicrobial peptides and methods of use
US20060008817A1 (en) 2000-12-08 2006-01-12 Invitrogen Corporation Methods and compositions for generating recombinant nucleic acid molecules
AU2002248173B2 (en) 2000-12-08 2007-04-26 Invitrogen Corporation Compositions and methods for rapidly generating recombinant nucleic acid molecules
WO2003027243A2 (en) 2001-09-27 2003-04-03 Pioneer Hi-Bred International, Inc. Phytate polynucleotides and methods of use
AU2003233489B2 (en) 2002-04-08 2008-10-02 Pioneer Hi-Bred International, Inc. Enhanced silk exsertion under stress
WO2003106672A2 (en) * 2002-06-12 2003-12-24 Riken METHOD FOR UTILIZING THE 5'END OF mRNA FOR CLONING AND ANALYSIS
EP1616947B1 (en) * 2003-03-28 2012-05-09 Japan as represented by Director General of National Rehabilitation Center for Persons with Disabilities METHOD OF SYNTHESIZING cDNA
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
GB0417887D0 (en) * 2004-08-11 2004-09-15 Ares Trading Sa Protein
JP5078038B2 (ja) * 2006-09-11 2012-11-21 国立大学法人大阪大学 微量ｍＲＮＡの増幅方法およびその利用
CN101932712B (zh) 2007-11-20 2014-05-14 先锋国际良种公司 用于改善植物应激耐性的玉米乙烯信号转导基因及其调节
US20100035249A1 (en) * 2008-08-05 2010-02-11 Kabushiki Kaisha Dnaform Rna sequencing and analysis using solid support
US8716553B2 (en) 2009-03-02 2014-05-06 Pioneer Hi Bred International Inc NAC transcriptional activators involved in abiotic stress tolerance
WO2011017492A2 (en) 2009-08-05 2011-02-10 Pioneer Hi-Bred International, Inc. Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
US8822663B2 (en) 2010-08-06 2014-09-02 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
AU2011308496A1 (en) 2010-10-01 2013-05-02 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
DE12722942T1 (de) 2011-03-31 2021-09-30 Modernatx, Inc. Freisetzung und formulierung von manipulierten nukleinsäuren
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
WO2013052523A1 (en) 2011-10-03 2013-04-11 modeRNA Therapeutics Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
AR088515A1 (es) 2011-10-25 2014-06-18 Pioneer Hi Bred Int Metodos para alterar la composicion de la pared celular vegetal para obtener produccion de biocombustible y digestibilidad de silaje mejoradas
CA2859387A1 (en) 2011-12-16 2013-06-20 Moderna Therapeutics, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
WO2013151669A1 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
EP2684954A1 (en) * 2012-07-10 2014-01-15 Lexogen GmbH 5´ protection dependent amplification
US9422602B2 (en) * 2012-08-15 2016-08-23 Bio-Rad Laboratories, Inc. Methods and compositions for determining nucleic acid degradation
US9597380B2 (en) 2012-11-26 2017-03-21 Modernatx, Inc. Terminally modified RNA
WO2014144767A1 (en) 2013-03-15 2014-09-18 Moderna Therapeutics, Inc. Ion exchange purification of mrna
US11377470B2 (en) 2013-03-15 2022-07-05 Modernatx, Inc. Ribonucleic acid purification
EP2971165A4 (en) 2013-03-15 2016-11-23 Moderna Therapeutics Inc DISSOLUTION OF DNA FRAGMENTS IN MRNA MANUFACTURING METHODS
BR112015023703A2 (pt) 2013-03-15 2017-07-18 Pioneer Hi Bred Int modulação de expressão de deaminase de acc
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
US10138507B2 (en) 2013-03-15 2018-11-27 Modernatx, Inc. Manufacturing methods for production of RNA transcripts
HRP20211563T1 (hr) 2013-07-11 2022-01-07 Modernatx, Inc. Pripravci koji sadrže sintetske polinukleotide koji kodiraju proteine srodne crispr-u i sintetske sgrna, te postupci njihove uporabe
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
US10385088B2 (en) 2013-10-02 2019-08-20 Modernatx, Inc. Polynucleotide molecules and uses thereof
EP3052521A1 (en) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
US11479766B2 (en) * 2013-12-05 2022-10-25 New England Biolabs, Inc. Methods for labeling a population of RNA molecules
JP2017522028A (ja) 2014-07-16 2017-08-10 モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． 環状ポリヌクレオチド
WO2017049286A1 (en) 2015-09-17 2017-03-23 Moderna Therapeutics, Inc. Polynucleotides containing a morpholino linker
WO2017066797A1 (en) 2015-10-16 2017-04-20 Modernatx, Inc. Trinucleotide mrna cap analogs
ES2914225T3 (es) 2015-10-16 2022-06-08 Modernatx Inc Análogos de cap de ARNm con enlace de fosfato modificado
DK3409773T3 (da) 2016-01-27 2020-09-07 Dnaform Kk Fremgangsmåde til afkodning af basesekvens af nukleinsyrer svarende til terminalt RNA-område og fremgangsmåde til analyse af DNA-element
SG11201901941YA (en) 2016-09-14 2019-04-29 Modernatx Inc High purity rna compositions and methods for preparation thereof
MA49922A (fr) 2017-08-18 2021-06-02 Modernatx Inc Procédés pour analyse par clhp
MA49914A (fr) 2017-08-18 2021-04-21 Modernatx Inc Procédés analytiques par hplc
WO2023127774A1 (ja) * 2021-12-28 2023-07-06 株式会社ダナフォーム 遺伝子包含体の検出方法及び検出用キット
WO2023237703A1 (en) 2022-06-09 2023-12-14 Vestlandets Innovasjonsselskap As Method of characterizing capped rna

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661450A (en) * 1983-05-03 1987-04-28 Molecular Genetics Research And Development Limited Partnership Molecular cloning of RNA using RNA ligase and synthetic oligonucleotides
US4710566A (en) * 1984-12-27 1987-12-01 Yale University Purification of the messenger RNA cap-binding protein
US5273879A (en) * 1987-07-23 1993-12-28 Syntex (U.S.A.) Inc. Amplification method for polynucleotide assays
CA2005252C (en) * 1988-12-13 2001-07-17 Nahum Sonenberg Isolation of full-length cdna clones and capped mrna
US5219989A (en) * 1988-12-13 1993-06-15 Mcgill University Bifunctional protein for the isolation of capped mRNA
US5324829A (en) * 1988-12-16 1994-06-28 Ortho Diagnostic Systems, Inc. High specific activity nucleic acid probes having target recognition and signal generating moieties
JP3315439B2 (ja) * 1992-07-21 2002-08-19 住友電気工業株式会社 細胞特異的ｃＤＮＡの分離法及びライブラリー作製法
JP3337748B2 (ja) * 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー 完全長ｃＤＮＡの合成方法、その中間体の製造方法及び完全長ｃＤＮＡを含む組換えベクターの製造方法

Also Published As

Publication number Publication date
DE69624695D1 (de) 2002-12-12
DE69624695T2 (de) 2003-07-31
CA2220045A1 (fr) 1996-11-07
DK0824598T3 (da) 2003-03-10
ATE227346T1 (de) 2002-11-15
WO1996034981A3 (fr) 1997-01-03
AU5982996A (en) 1996-11-21
JPH11510364A (ja) 1999-09-14
CA2220045C (fr) 2001-10-30
US6022715A (en) 2000-02-08
AU719217B2 (en) 2000-05-04
EP0824598A2 (fr) 1998-02-25
FR2733762B1 (fr) 1997-08-01
WO1996034981A2 (fr) 1996-11-07
FR2733762A1 (fr) 1996-11-08
EP0824598B1 (fr) 2002-11-06
ES2186778T3 (es) 2003-05-16

Similar Documents

Publication Publication Date Title
PT824598E (pt) Processo para o acoplamento especifico de um grupo de bloqueio da extremidade 5' de um fragmento de arnm e preparacao do arnm e do adnc completo
BR9609837A (pt) Processo para purificação de vírus por cromatografia
DK0810981T3 (da) Fremgangsmåde til fremstilling af et mineraluldsprodukt
PT835257E (pt) Intermediarios e processo para o fabrico de derivados camptotecina (cpt-11) e compostos relacionados
BR0108353A (pt) Método de filtração de fluxo proveniente de laticìnios
DE50102614D1 (de) Verfahren zur herstellung von aluminosilicatgläsern
DE69131962T2 (de) Verfahren und vorrichtung für die fragmentation von biomaterialien
ATE242363T1 (de) Brechbarer pfostenverbinder
SE9502921D0 (sv) New compounds
BR9911137A (pt) Processo para tratamento de correntes de fluido
BR0007610A (pt) Método para preparação de cloridrato del-fenilefrina
TR199501122A2 (tr) Etil alkol üretim yöntemi.
BR9610161A (pt) Processo de hidrogenação de nitrilas
ATE266037T1 (de) Verfahren zur herstellung von phoshphorothioate triestere
DE60124289D1 (de) Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
DE69830079D1 (de) Verfahren zur verringerung des aox anteils in nassfesten harzen durch behandlung mit base
NO971723D0 (no) Fremgangsmåte ved rensning av vandige, tertiære aminoksydopplösninger
BR9502692A (pt) Processo de refino de descarbonetação de aço fundido contendo cr.
ATE308571T1 (de) Verfahren zur herstellung von hydrierten aromatischen polymerzusammensetzungen
BR9713569A (pt) Processo para a redução de corantes de enxofre e de cuba.
BR9807785A (pt) Processo para a preparação do composto, e, composto
MA26450A1 (fr) Dimesylate de cis-1-(3-ethoxyphenyl)-1-(4-phenyl-piperazine-1-yl)-4-methylcyclohexane, procede pour sa preparation et composition pharmaceutique.
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
PT937094E (pt) Processo para a preparacao de ivermectina
DK0746325T3 (da) Kaloriefattig lakserende gelé på basis af flydende paraffinolie samt lactulose, og fremgangsmåde til fremstilling heraf